Connect your AI

Cerus CERS Change in Other Assets

Change in Other Assets at other companies

CorMedixCRMD

$2.26M-0.4%

Protagonist TherapeuticsPTGX

$1.92M+102%

ADMA BiologicsADMA

$1.6M-38.3%

PaysignPAYS

$1.31M+895%

Other financials

Income statement

Revenue$53.7M+24.1%

Operating income-$354.0K+94.0%

Net income-$1.6M+78.7%

EPS (diluted)-$0.01+75.0%

Balance sheet

Cash & equivalents$27.9M+43.0%

Total debt$45.0M-43.3%

Total equity$67.6M+21.7%

Total assets$222.9M+7.8%

Cash flow

Operating cash flow-$3.0M-261%

CapEx$233.0K+108%

Free cash flow-$3.3M-243%

Valuation

Market cap$573.06M+124%

Enterprise value$590.17M+86.7%

P/S2.9×-1.0×

Profitability

Gross margin64%—

Operating margin-6.2%-2.1pp

Net margin-9.8%-2.8pp

FCF margin3.5%+1.9pp

Returns & leverage

Return on equity-15.5%-5.6pp

Debt / equity0.7×-0.8×

Current ratio1.6×-0.7×

Where this comes from

Reported directly by Cerus in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Cerus’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cerus's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Cerus's change in other assets?: Cerus (CERS) reported change in other assets of -$542K in Q1 2026.
How has Cerus's change in other assets changed year-over-year?: Cerus's change in other assets decreased by 123.4% year-over-year, from $2.31M to -$542K.
What does change in other assets mean?: Change in miscellaneous assets affecting operating cash flow.